Raising Dividends for 54 Consecutive Years to Reward Shareholders, Abbott Laboratories’ Diversified Layout Consolidates Its Growth Foundation Life Science
UnitedHealth Group Stock Rises 37% Year-to-Date, Market Sees Path Back to All-Time Highs Life Science
Johnson & Johnson Posts Solid Quarter, Yet Wall Street Sells Off – What Spooked Investors? Life Science
Intuitive Surgical’s Stock Has Fallen Over 25% This Year, but Goldman Sachs Still Recommends Investors Buy Life Science
Two Overhyped GLP-1 Stocks Present Buying Opportunities on Dips, with Novo Nordisk and Kailera Therapeutics Each Offering Unique Highlights Life Science
WELL Health Delivers Record Profits — Is This 53% Discount a Buying Opportunity? Life Science, Technology
The Market Has Responded Coolly to Vertex’s Multibillion-Dollar Acquisition, but Management’s Track Record and Integration Capabilities Add Confidence to the Deal Life Science
The Panic of a Plunge Cannot Avoid Market Cycles, but Long-Term Holding of Quality Assets Can Secure the Final Victory Life Science, Technology
Core Business Steady Growth Coupled with Acquisition Tailwinds, Vertex Pharmaceuticals Demonstrates Strong Post-Market Momentum Life Science
